4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-035085
CEO and CFO bought 1,500 shares at $13.62 ($20,430)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2026-07-27 | Purchase | +1,500 | $13.62 | $20,430 | 5,609,202 | D |
| Open-market purchases · 1,500 sh · avg $13.62 · $20,430 | |||||||
Loading xslF345X06/ownership.xml…